Author pages are created from data sourced from our academic publisher partnerships and public sources.
Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States
OBJECTIVE: To examine the use of inpatient hysterectomy and explore changes in the use of various routes of hysterectomy and patterns of referral. METHODS: The Nationwide Inpatient Sample was used to… Expand
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
- P. Goodfellow, B. Buttin, +7 authors D. Mutch
- Biology, Medicine
- Proceedings of the National Academy of Sciences…
- 5 May 2003
Endometrial cancer is the most common gynecologic malignancy in the United States and the most frequent extracolonic tumor in hereditary nonpolyposis colorectal cancer (HNPCC). HNPCC patients have… Expand
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
- B. Monk, T. Herzog, +17 authors A. M. Poveda
- Journal of clinical oncology : official journal…
- 1 July 2010
PURPOSE The objective of this study was to compare the efficacy and safety of trabectedin plus pegylated liposomal doxorubicin (PLD) with that of PLD alone in women with recurrent ovarian cancer… Expand
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a…
BACKGROUND Platinum-based chemotherapy doublets are a standard of care for women with ovarian cancer recurring 6 months after completion of initial therapy. In this study, we aimed to explore the… Expand
Contemporary management of endometrial cancer
The treatment of endometrial cancer has changed substantially in the past decade with the introduction of a new staging system and surgical approaches accompanied by novel adjuvant therapies. Primary… Expand
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast/Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and up to… Expand
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
Ovarian cancer is a heterogeneous, rapidly progressive, highly lethal disease of low prevalence. The etiology remains poorly understood. Numerous risk factors have been identified, the most prominent… Expand
Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease
Endometrial cancer: a review and current management strategies: part II.
Endometrial carcinoma is the most common gynecologic malignancy. A thorough understanding of the epidemiology, pathophysiology, and management strategies for this cancer allows the… Expand
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease.
IMPORTANCE Although robotically assisted hysterectomy for benign gynecologic conditions has been reported, little is known about the incorporation of the procedure into practice, its complication… Expand